SIOP treatment guidelines for renal tumours in small infants: Fact or fantasy?

European Journal of Surgical Oncology

Volumn 26, Issue 6, 2000, Pages 567-570

  Levie, N S ^a   De Kraker, J ^a   Bokkerink J P M ^b   Appel, I M ^c   Aronson, D C ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Congenital mesoblastic nephroma; Nephroblastoma; Renal tumour; Wilms' tumour

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PROTOCOL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MESOBLASTIC NEPHROMA; NEPHRECTOMY; NEPHROBLASTOMA; NEWBORN; PRACTICE GUIDELINE; PRIORITY JOURNAL; STILLBIRTH; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

EID: 0033783884     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.2000.0948     Document Type: Article

References (6)

1. Outcomes in low-risk babies treated with half-dose chemotherapy according to the Third National Wilms' Tumor Study
2. Epidemiology of Wilms' tumor
3. Preoperative care of infants with nephroblastoma. The SIOP 6 experience
4. Importance of the intraabdominal tumour extension at surgery for renal tumours in patients younger than 6 months. The SIOP nephroblastoma study no-9
5. Neonatal Wilms' tumor